JonesResearch upgraded Theratechnologies (THTX) to Buy from Hold with a $3 price target The Future Pak acquisition offer reflects favorably on the value of the Egrifta franchise, the analyst tells investors in a research note. The firm believes believe Theratechnologies “is on a favorable trajectory” following the elimination of supply restraints. Jones believes the unsolicited Future Pak acquisition offer demonstrates recognition of the Egrifta franchise value, but is more likely to fall through than close.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THTX:
- Theratechnologies: Buy Rating Upgrade Amid EGRIFTA Developments and Acquisition Interest
- Biotech Alert: Searches spiking for these stocks today
- Future Pak submits proposals to acquire Theratechnologies
- Theratechnologies Reports Strong Q1 2025 Growth
- Theratechnologies’ Earnings Call: Growth Amid Challenges